Morgan Stanley’s SeaStar Medical ICU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-20
Closed -$74 8497
2026
Q1
$74 Hold
20
﹤0.01% 7863
2025
Q4
$48 Sell
20
-60
-75% -$265 ﹤0.01% 7870
2025
Q3
$456 Sell
80
-4
-5% -$31 ﹤0.01% 7510
2025
Q2
$359 Sell
84
-6
-7% -$69 ﹤0.01% 7498
2025
Q1
$1.49K Buy
90
+30
+50% +$564 ﹤0.01% 7228
2024
Q4
$1.16K Sell
60
-40
-40% -$1.14K ﹤0.01% 7251
2024
Q3
$4.26K Sell
100
-1,090
-92% -$73K ﹤0.01% 6958
2024
Q2
$90.3K Sell
1,190
-4,450
-79% -$477K ﹤0.01% 5996
2024
Q1
$1.04M Buy
5,640
+5,440
+2,720% +$1.07M ﹤0.01% 4935
2023
Q4
$22.1K Buy
+200
New +$29.6K ﹤0.01% 6422
2023
Q1
Hold
0
-$12 7767
2022
Q4
Hold
0
7795

Other funds holding ICU

Morgan Stanley's ICU Position: Q2 2026 in Review

Morgan Stanley sold out of SeaStar Medical (ICU) in Q2 2026, closing a stake of 20 shares — an estimated $74 sold.

Morgan Stanley first reported a position in ICU in Q4 2023 and held it in 10 quarters. The position peaked at $1.04M in Q1 2024. 18 funds tracked by Wall St. Rank hold ICU as of Q2 2026.

  • Morgan Stanley reported no remaining SeaStar Medical position as of Q2 2026 after selling out during the quarter.
  • Morgan Stanley sold 20 SeaStar Medical shares in Q2 2026, an estimated $74.
  • Morgan Stanley first reported a position in SeaStar Medical in Q4 2023 and held it in 10 quarters.
  • Morgan Stanley's SeaStar Medical position peaked at $1.04M in Q1 2024.
  • 18 funds tracked by Wall St. Rank held SeaStar Medical as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.